Literature DB >> 3495516

Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak.

A E Bacon, K A Jorgensen, K H Wilson, C A Kauffman.   

Abstract

At the Ann Arbor Veterans Administration Medical Center, 30 patients over a 6-month period became nosocomially infected or colonized by methicillin-resistant Staphylococcus aureus. Immediate institution of strict infection control measures, in conjunction with surveillance cultures of personnel and treatment of carriers, did not limit spread of the outbreak strain of MRSA. Multiple nonoutbreak strains, phenotypically exhibiting heteroresistance, were also uncovered. Thirteen hospital personnel were identified as MRSA carriers. Trimethoprim-sulfamethoxazole (TMP-SMX) and rifampin initially eradicated the carrier state, documented by anterior nares cultures in 13 courses of treatment in 11 employees. However, three employees were recolonized, one at one month, one at both one and four months, and one at four months. Treatment of the carrier state reservoir among personnel appeared to have no effect on the emergence and spread of nosocomial MRSA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495516     DOI: 10.1017/s0195941700065802

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  12 in total

1.  Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus.

Authors:  A Bouvet; J M Fournier; A Audurier; C Branger; A Orsoni; C Girard
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Dynamics of nasal carriage of methicillin-resistant Staphylococcus aureus among healthcare workers in a tertiary-care hospital in Peru.

Authors:  C Garcia; A Acuña-Villaorduña; A Dulanto; S Vandendriessche; M Hallin; J Jacobs; O Denis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-29       Impact factor: 3.267

3.  Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

Authors:  E A Piercy; D Barbaro; J P Luby; P A Mackowiak
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

4.  Methicillin-resistant Staphylococcus aureus: associated morbidity and effectiveness of control measures.

Authors:  M R Law; O N Gill; A Turner
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

5.  Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.

Authors:  T J Walsh; H C Standiford; A C Reboli; J F John; M E Mulligan; B S Ribner; J Z Montgomerie; M B Goetz; C G Mayhall; D Rimland
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Diversity and stability of restriction enzyme profiles of plasmid DNA from methicillin-resistant Staphylococcus aureus.

Authors:  A J Zuccarelli; I Roy; G P Harding; J J Couperus
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

7.  The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Authors:  Andrew E Simor; Mark Loeb
Journal:  Can J Infect Dis       Date:  2004-01

8.  Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients.

Authors:  Scott K Fung; Marie Louie; Andrew E Simor
Journal:  Can J Infect Dis       Date:  2002-09

9.  Unusually large number of methicillin-resistant Staphylococcus aureus clones in a Portuguese hospital.

Authors:  I Couto; J Melo-Cristino; M L Fernandes; T Garcia; N Serrano; M J Salgado; A Torres-Pereira; I S Sanches; H de Lencastre
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Increasing resistance of Staphylococcus aureus to ciprofloxacin.

Authors:  T E Daum; D R Schaberg; M S Terpenning; W S Sottile; C A Kauffman
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.